Human Genome Epidemiology Literature Finder
|
Records 1 - 18 (of 18 Records) |
| Query Trace: Glioma and MUT[original query] |
|---|
| Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomas. Brain tumor pathology 2013 Mar . Ohno M, Narita Y, Miyakita Y, Matsushita Y, Yoshida A, Fukushima S, Ichimura K, Shibui S |
| TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations. British journal of cancer 2014 Nov 111 (10): 2024-32. Labussière M, Di Stefano A L, Gleize V, Boisselier B, Giry M, Mangesius S, Bruno A, Paterra R, Marie Y, Rahimian A, Finocchiaro G, Houlston R S, Hoang-Xuan K, Idbaih A, Delattre J-Y, Mokhtari K, Sanson |
| Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
| TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas. Oncotarget 2015 Jul . Zhang Zhen-Yu, Chan Aden Ka-Yin, Ding Xiao-Jie, Qin Zhi-Yong, Hong Christopher S, Chen Ling-Chao, Zhang Xin, Zhao Fang-Ping, Wang Yin, Wang Yang, Zhou Liang-Fu, Zhuang Zhengping, Ng Ho-Keung, Yan Hai, Yao Yu, Mao Yi |
| TERT promoter mutated WHO grades II and III gliomas are located preferentially in the frontal lobe and avoid the midline. International journal of clinical and experimental pathology 2015 8 (9): 11485-94. Sun Ze-Lin, Chan Aden Ka-Yin, Chen Ling-Chao, Tang Chao, Zhang Zhen-Yu, Ding Xiao-Jie, Wang Yang, Sun Chong-Ran, Ng Ho-Keung, Yao Yu, Zhou Liang- |
| Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT. Acta neuropathologica 2017 Mar . Pekmezci Melike, Rice Terri, Molinaro Annette M, Walsh Kyle M, Decker Paul A, Hansen Helen, Sicotte Hugues, Kollmeyer Thomas M, McCoy Lucie S, Sarkar Gobinda, Perry Arie, Giannini Caterina, Tihan Tarik, Berger Mitchel S, Wiemels Joseph L, Bracci Paige M, Eckel-Passow Jeanette E, Lachance Daniel H, Clarke Jennifer, Taylor Jennie W, Luks Tracy, Wiencke John K, Jenkins Robert B, Wrensch Margaret |
| TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data. Critical reviews in oncology/hematology 2017 Dec 120 1-9. Vuong Huy Gia, Altibi Ahmed M A, Duong Uyen N P, Ngo Hanh T T, Pham Thong Quang, Chan Aden Ka-Yin, Park Chul-Kee, Fung Kar-Ming, Hassell Lew |
| Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma. Neuro-oncology 2017 Aug . Suchorska Bogdana, Giese Armin, Biczok Annamaria, Unterrainer Marcus, Weller Michael, Drexler Mark, Bartenstein Peter, Schüller Ulrich, Tonn Jörg-Christian, Albert Nathalie |
| Predicting IDH genotype in gliomas using FET PET radiomics. Scientific reports 2018 Sep 8 (1): 13328. Lohmann Philipp, Lerche Christoph, Bauer Elena K, Steger Jan, Stoffels Gabriele, Blau Tobias, Dunkl Veronika, Kocher Martin, Viswanathan Shivakumar, Filss Christian P, Stegmayr Carina, Ruge Maximillian I, Neumaier Bernd, Shah Nadim J, Fink Gereon R, Langen Karl-Josef, Galldiks Norbe |
| Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning. European journal of cancer (Oxford, England : 1990) 2018 12 107 15-27. Suchorska Bogdana, Schüller Ulrich, Biczok Annamaria, Lenski Markus, Albert Nathalie L, Giese Armin, Kreth Friedrich-Wilhelm, Ertl-Wagner Birgit, Tonn Jörg-Christian, Ingrisch Micha |
| Understanding cognitive functioning in glioma patients: The relevance of IDH-mutation status and functional connectivity. Brain and behavior 2019 2 9 (4): e01204. Derks Jolanda, Kulik Shanna, Wesseling Pieter, Numan Tianne, Hillebrand Arjan, van Dellen Edwin, de Witt Hamer Philip C, Geurts Jeroen J G, Reijneveld Jaap C, Stam Cornelis J, Klein Martin, Douw Lin |
| ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data. Radiation oncology (London, England) 2020 Jul 15 (1): 184. Kim Nalee, Kim Se Hoon, Kang Seok-Gu, Moon Ju Hyung, Cho Jaeho, Suh Chang-Ok, In Yoon Hong, Chang Jong H |
| Is There an Independent Role of TERT and NF1 in High Grade Gliomas? Translational oncology 2019 Dec 13 (2): 346-354. Razis Evangelia, Kotoula Vassiliki, Koliou Georgia-Angeliki, Papadopoulou Kyriaki, Vrettou Eleni, Giannoulatou Eleni, Tikas Ioannis, Labropoulos Stefanos V, Rigakos Georgios, Papaemmanoyil Styliani, Romanidou Ourania, Bourkoula Eugenia, Nomikos Panagiotis, Iliadis Georgios, Nasioulas George, Selviaridis Panagiotis, Polyzoidis Konstantinos, Fountzilas Geor |
| Pro-inflammatory and proliferative microglia drive progression of glioblastoma. Cell reports 2021 9 36 (11): 109718. Liu Hailong, Sun Youliang, Zhang Qian, Jin Wei, Gordon Renata E, Zhang Yanyang, Wang Jian, Sun Caihong, Wang Zeyuan John, Qi Xueling, Zhang Junping, Huang Boyuan, Gui Qiuping, Yuan Hongyu, Chen Ling, Ma Xiaodong, Fang Chuan, Liu Yong-Qiang, Yu Xinguang, Feng Shi |
| Identification of the Prognostic Signatures of Glioma With Different PTEN Status. Frontiers in oncology 2021 8 11 633357. Zhang Pei, Meng Xinyi, Liu Liqun, Li Shengzhen, Li Yang, Ali Sakhawat, Li Shanhu, Xiong Jichuan, Liu Xuefeng, Li Shouwei, Xia Qin, Dong L |
| High IER5 Gene Expression Is Associated With Poor Prognosis in Glioma Patients. Frontiers in cell and developmental biology 2021 7 9 679684. Wu Zijun, Wang Dan, Zeng Fanxin, Zhang Yanrong, Zhu Guannan, Ma Yiqi, Song Bin, Lui Su, Wu M |
| Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma. Journal of neuro-oncology 2021 1 152 (1): 27-36. Bu Linghao, Hameed N U Farrukh, Luo Chen, Hong Pengjie, Zhou Xiaoyu, Wang Shengzhou, Wu Shu |
| A prognostic risk model for glioma patients by systematic evaluation of genomic variations. iScience 2022 12 25 (12): 105681. Zhang Baifeng, Wan Weiqing, Li Zibo, Gao Zhixian, Ji Nan, Xie Jian, Wang Junmei, Wang Bin, Lai-Wan Kwong Dora, Guan Xinyuan, Gao Shengjie, Zhao Yuanli, Lu Youyong, Zhang Liwei, Rodland Karin D, Tsang Shirley |
- Page last reviewed:Feb 1, 2024
- Content source: